PINK1 and its familial Parkinson's disease-associated mutation regulate brain vascular endothelial inflammation

Journal of Molecular Neuroscience

Volumn 53, Issue 1, 2014, Pages 109-116

  Wang, Yunfu ^a   Liu, Guangjian ^a   Ping, Zhong ^a   Sun, Yanpeng ^a   Fang, Xiaoxia ^a   Wei, Hu ^a   Jiang, Yuan ^a   Hu, Jingquan ^a   Wang, Songlin ^a   Zhang, Hongyan ^a   Yong, Liu ^a   Shi, Chen ^b  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Interferon regulatory factor 1 (IRF 1); Parkinson's disease; PINK1; Vascular inflammation

Indexed keywords

INTERFERON REGULATORY FACTOR 1; PHOSPHOTRANSFERASE; PTEN INDUCED PUTATIVE KINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; IRF1 PROTEIN, HUMAN; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN BRAIN MICROVASCULAR ENDOTHELIAL CELL; HUMAN CELL; LOSS OF FUNCTION MUTATION; MICROVASCULAR ENDOTHELIAL CELL; MONOCYTE; PARKINSON DISEASE; PROTEIN EXPRESSION; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; INFLAMMATION; METABOLISM; MUTATION; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

CELL LINE, TUMOR; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; MUTATION; PARKINSON DISEASE; PROTEIN KINASES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84899913647     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0207-1     Document Type: Article

References (23)

1. Abou-Sleiman PM, Muqit MM, McDonald NQ, Yang YX, Gandhi S et al (2006) A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol 60(4):414-419 (Pubitemid 44684977)
2. Belin AC, Westerlund M (2008) Parkinson's disease: a genetic perspective. FEBS J 275:1377-1383 (Pubitemid 351388789)
3. Blackinton JG, Anvret A, Beilina A, Olson L, Cookson MR et al (2007) Expression of PINK1 mRNA in human and rodent brain and in Parkinson's disease. Brain Res 1184:10-16 (Pubitemid 350161884)
4. Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J et al (2005) 6-Hydroxydopamineinduced alterations in blood-brain barrier permeability. Eur J Neurosci 22:1158-1168 (Pubitemid 41395380)
5. Corti O, Brice A (2013) Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease. Curr Opin Neurobiol 23:100-108
6. Farkas E, De Jong GI, de Vos RA, Jansen Steur EN, Luiten PG (2000) Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol 100: 395-402 (Pubitemid 30497009)
7. Grammas P, Martinez J, Miller B, Grammas P, Martinez J, Miller B (2011) Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 25:8-26
8. Hoepken HH, Gispert S, Morales B, Wingerter O, Del Turco D et al (2007)Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis 25:401-411 (Pubitemid 46124020)
9. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC (1992) Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 267:16323-163239
10. Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J et al (2005) Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57:176-179 (Pubitemid 40179854)
11. Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson's disease: role for cytokines. Curr Pharm Des 11:999-1016 (Pubitemid 40331301)
12. Nizamutdinova IT, Kim YM, Chung JI, Shin SC, Jeong YK et al (2009) Anthocyanins from black soybean seed coats preferentially inhibit TNF-alpha-mediated induction of VCAM-1 over ICAM-1 through the regulation of GATAs and IRF-1. J Agric Food Chem 57:7324-7330
13. Sánchez-Mora RM, Arboleda H, Arboleda G (2012) PINK1 overexpression protects against C2-ceramide-induced CAD cell death through the PI3K/AKT pathway. J Mol Neurosci 47(3):582-594
14. Sheng B, Wang X, Su B, Lee HG, Casadesus G et al (2012) Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem 120(3):419-429
15. Shi H, Sheng B, Zhang F (2013) Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function. Am J Physiol Heart Circ Physiol 304(6):H796-H805
16. Silvestri L, Caputo V, Bellacchio E et al (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14:3477-3492 (Pubitemid 41672130)
17. Singleton AB, Farrer MJ, Bonifati V (2013) The genetics of Parkinson's disease: progress and therapeutic implications. Mov Disord 28(1):14-23
18. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314
19. Sun C, Alkhoury K, Wang YI, Foster GA, Radecke CE et al (2012) IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-652 fat meal. Circ Res 111:1054-1064
20. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S et al (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160 (Pubitemid 38661852)
21. Wang HL, Chou AH, Yeh TH, Li AH, Chen YL et al (2007) PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiol Dis 28(2):216-226 (Pubitemid 47615460)
22. Yuan XL, Guo JF, Shi ZH, Xiao ZQ, Yan XX et al (2010) R492X mutation in PTEN-induced putative kinase 1 induced cellular mitochondrial dysfunction and oxidative stress. Brain Res 1351:229-237
23. Zhou G, Hamik A, Nayak L et al (2012) Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice. J Clin Invest 122(12):4727-4731